Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
49°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
168.39
-1.15 (-0.68%)
Streaming Delayed Price
Updated: 11:44 AM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
3 Magnificent Growth Stocks to Buy Right Now
February 19, 2024
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.
Via
The Motley Fool
3 Cash Cows to Boost Your Confidence During the February Chill
February 18, 2024
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Via
InvestorPlace
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning
February 16, 2024
Via
Investor Brand Network
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
February 14, 2024
A Relative Strength Rating upgrade for AbbVie shows improving technical performance.
Via
Investor's Business Daily
AbbVie Options Trading: A Deep Dive into Market Sentiment
February 07, 2024
Via
Benzinga
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning
February 07, 2024
Via
Investor Brand Network
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit
February 14, 2024
A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses.
Via
Benzinga
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
February 06, 2024
Via
Benzinga
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
February 06, 2024
These two dividend-growth stocks are fantastic buys.
Via
The Motley Fool
The 7 Best Momentum Stocks You Can Purchase Today
February 12, 2024
If you’re looking for hot opportunities in the market, here are just a few of the best momentum stocks to buy today.
Via
InvestorPlace
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
These incredible businesses have long histories of successes behind them, and more to come.
Via
The Motley Fool
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
February 11, 2024
The drugmaker is handling its biggest obstacle yet relatively well.
Via
The Motley Fool
Jim Cramer Looks At Blackstone, Praises MercadoLibre: 'They're Incredibly Smart'
February 09, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all...
Via
Benzinga
3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?
February 08, 2024
Letting your winners run is a proven way to generate extraordinary portfolio returns without cutting them off by taking profits.
Via
InvestorPlace
AbbVie Analysts Boost Their Forecasts Following Strong Earnings
February 05, 2024
AbbVie Inc (NYSE: ABBV) reported better-than-expected fourth-quarter earnings on Friday.
Via
Benzinga
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
February 06, 2024
Unveil these standout Russell 2000 stocks, meticulously picked to harness the potential of the evolving market landscape in the 2024 surge.
Via
InvestorPlace
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
UBS bullish on Axsome's Auvelity launch and pipeline, foreseeing $1 billion sales by 2030. Buy rating, $111 price target. Positive Phase 3 data for Alzheimer's Agitation and Narcolepsy.
Via
Benzinga
7 Dividend Stocks Worth Holding for the Long Haul
February 06, 2024
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.
Via
InvestorPlace
Why AbbVie Stock Flew Higher on Monday
February 05, 2024
Investors and pundits alike continued to be impressed by the company's latest earnings report.
Via
The Motley Fool
Drug Maker AbbVie Stock Sees RS Rating Jump To 81
February 05, 2024
AbbVie stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 78 to 81.
Via
Investor's Business Daily
Better Dividend Stock: Pfizer vs. AbbVie
February 05, 2024
Both offer above-average yields but which can deliver the most dividend income over the long run?
Via
The Motley Fool
Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday
February 05, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
3 Fabulous Dividend Stocks to Buy in February
February 04, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
7 Dividend Stocks That Pay Me More Than $500 Per Month
February 03, 2024
These stocks pay safe, reliable, and growing dividends.
Via
The Motley Fool
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
February 02, 2024
ABBV earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
February 02, 2024
The Dow led the major indexes higher. Big techs diverged on results.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.